CC
CDIO icon

Centiva Capital’s Cardio Diagnostics CDIO Stock Holding History

Centiva Capital’s Portfolio CDIO Stock Details CDIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,633
Closed -$793K – 1383
2022
Q3 		$793K Hold
2,633
– – 0.01% 715
2022
Q2 		$785K Hold
2,633
– – 0.02% 726
2022
Q1 		$780K Buy
+2,633
New +$778K 0.01% 800

Other funds holding CDIO

LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $265M AUM 30.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Centiva Capital's CDIO Position: Q4 2022 in Review

Centiva Capital sold out of Cardio Diagnostics (CDIO) in Q4 2022, closing a stake of 2,633 shares — an estimated $793K sold.

Centiva Capital first reported a position in CDIO in Q1 2022 and held it in 3 quarters. The position peaked at $793K in Q3 2022. 11 funds tracked by Wall St. Rank hold CDIO as of Q4 2022.

  • Centiva Capital reported no remaining Cardio Diagnostics position as of Q4 2022 after selling out during the quarter.
  • Centiva Capital sold 2,633 Cardio Diagnostics shares in Q4 2022, an estimated $793K.
  • Centiva Capital first reported a position in Cardio Diagnostics in Q1 2022 and held it in 3 quarters.
  • Centiva Capital's Cardio Diagnostics position peaked at $793K in Q3 2022.
  • 11 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q4 2022.

Based on Centiva Capital's 13F filing for Q4 2022, filed 14 Feb 2023.